IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$415M
AUM Growth
+$35.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
76
New
Increased
Reduced
Closed

Top Buys

1
+$14.4M
2
+$14.3M
3
+$10.9M
4
INCY icon
Incyte
INCY
+$9.18M
5
TVTX icon
Travere Therapeutics
TVTX
+$8.73M

Top Sells

1
+$17.8M
2
+$14M
3
+$7.77M
4
XLRN
Acceleron Pharma
XLRN
+$7.59M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$6.81M

Sector Composition

1 Healthcare 98.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$28.1M 6.78%
402,784
2
$27.7M 6.69%
289,500
+82,500
3
$26M 6.28%
237,873
4
$25.1M 6.06%
118,300
+67,300
5
$24.5M 5.91%
176,400
6
$18.6M 4.49%
109,700
-35,300
7
$18.6M 4.48%
270,360
+133,500
8
$17.4M 4.2%
98,500
+81,600
9
$16.7M 4.03%
449,000
10
$14.2M 3.42%
75,000
-74,000
11
$14M 3.38%
77,222
+12,400
12
$10.9M 2.64%
+27,756
13
$10.3M 2.49%
489,534
+388,000
14
$9.29M 2.24%
103,100
+43,000
15
$9.22M 2.22%
138,741
+17,200
16
$9.21M 2.22%
380,000
+360,000
17
$9.02M 2.18%
236,000
+70,000
18
$7.93M 1.91%
297,500
+95,064
19
$7.21M 1.74%
25,500
-23,000
20
$7.13M 1.72%
94,300
+36,200
21
$6.69M 1.61%
383,233
+100,000
22
$6.64M 1.6%
241,100
+141,000
23
$5.83M 1.41%
182,194
-133,306
24
$5.75M 1.39%
44,200
+24,200
25
$4.69M 1.13%
29,400
+15,600
1
2 3 4